全球牙科膜和移植骨替代物市場規模（按膜類型、移植骨替代物類型、最終用戶、地區、範圍和預測）

牙科膜和移植骨替代物市場規模和預測

2024 年牙科膜和移植骨替代物市場規模價值 20.7 億美元，預計到 2032 年將達到 39.7 億美元，2026 年至 2032 年的複合年成長率為 8.46%。

牙膜和移植骨替代物是用於人工植牙手術的材料，用於促進骨再生和組織修復。牙膜用於覆蓋和保護骨移植，並確保其與周圍骨骼良好融合。骨移植是當骨骼密度不足以支撐植入時，用於替代或補充天然骨的材料。這些替代物可以是合成的、源自其他動物的，也可以是人體組織製成的。它們在引導骨再生和竇增高術等手術中至關重要，有助於恢復失去的骨結構並促進新骨形成。

隨著材料科學的進步，以及牙科問題和美容手術日益增多帶來的牙科植入需求的不斷成長，牙科膜和移植骨替代物市場預計將迅速擴張。生物材料的創新，例如生物活性和可吸收膜及移植物的研發，預計將提升這些產品的有效性。

它與幹細胞療法和組織工程等再生醫學方法的結合可能會拓寬其應用範圍。人口老化和人們對口腔健康的認知不斷提高預計將推動市場的擴張，並為新的和改進的牙科再生解決方案開闢前景。

全球牙科膜和移植骨替代物市場動態

關鍵市場促進因素

牙科疾病和牙齒脫落發病率不斷上升：市場成長主要受牙科疾病和牙齒脫落發病率不斷上升的驅動。根據世界衛生組織 (WHO) 的數據，全球約有 35 億人患有口腔疾病，其中最常見的是未治療的恆牙齲齒（蛀牙），影響 23 億人。

老齡人口不斷成長：老年人口的成長增加了對牙膜和骨移植的需求，因為他們面臨更大的牙齒問題和牙齒脫落的風險。根據聯合國經濟和社會事務部的數據，到2050年，全球每六人中就有一人年齡超過65歲（佔總人口的16%），而2019年這一比例為每十一人中就有一人（佔總人口的9%）。

牙科旅遊日益流行，尤其是在較貧窮的國家，這導致對現代牙科護理的需求不斷成長。根據「無國界患者」（Patients Beyond Borders）組織的數據，牙科旅遊市場規模預計在2021年達到58.3億美元，2022年至2030年的複合年成長率為12.1%。

主要挑戰

法規合規性：確保跨地區的法規合規性是一項重要任務。牙科膜和骨移植必須符合美國藥物管理局 (FDA) 和歐洲藥品管理局 (EMA) 等衛生機構制定的嚴格要求。滿足這些要求需要進行大量的測試和記錄，這既耗時又耗費成本。各國監管標準的差異可能會使國際市場准入變得複雜，並增加違規的風險，從而延遲產品上市並限制市場准入。

患者個別差異：患者健康狀況、骨質和癒合反應的個別差異都會影響人工植牙治療的成功率。患者反應的差異使得生產通用有效的牙膜和骨移植替代品變得困難。開發滿足不同患者需求的產品需要進一步研究和客製化，這使得產品開發更加複雜且成本高昂。

臨床證據有限：新型牙科膜或骨移植的有效性必須有強而有力的臨床證據支持。臨床數據不足或不確定可能會阻礙產品的採用和市場認可。確保產品已通過廣泛且充分的臨床試驗證明其安全有效。缺乏強力的臨床數據也可能導致牙科相關人員的不信任，從而損害產品的可信度。

主要趨勢：

生物分解性材料：人們對開發生物分解性的牙科膜和骨移植替代材料的興趣日益濃厚。這些材料旨在隨著時間的推移自然分解並被人體吸收，無需手術切除，並減少潛在的副作用。生物分解性的解決方案可提高患者的舒適度，同時降低長期副作用的風險。材料科學的發展正在推動開發更有效、更安全的生物分解性解決方案，從而支持致力於改善患者治療效果和加快牙科手術速度的行業。

3D列印技術：3D列印技術正在改變牙科膜和移植骨替代物市場，因為它能夠製造高度客製化和精準的產品。該技術能夠創建具有複雜特徵的患者專用植入和移植物，精確匹配患者的解剖學要求。它還支援快速原型製作和新材料的開發。根據個人需求客製化產品的能力提高了牙科治療的有效性，並拓展了移植骨替代物在再生牙科領域的潛在應用。

更重視以病人為中心的照護：牙科護理領域日益重視以病人為中心的服務，這推動了牙科膜和骨移植替代品的發展。這一趨勢凸顯了開發不僅能改善治療效果，還能提升患者整體體驗的產品的必要性。舒適性、易用性和縮短恢復時間在產品開發中變得越來越重要。透過滿足這些患者需求，公司希望開發出更有效、更方便患者的解決方案。

目錄

第1章 引言

• 市場定義
• 市場區隔
• 調查方法

第2章執行摘要

• 主要發現
• 市場概覽
• 市場亮點

第3章市場概述

• 市場規模和成長潛力
• 市場趨勢
• 市場促進因素
• 市場限制
• 市場機會
• 波特五力分析

4. 牙科膜和移植骨替代物市場（按膜類型）

• 可吸收膜
• 不可吸收膜

5. 牙科膜和移植骨替代物市場（按骨移植類型）

• 同種異體移植
• 異質骨移植
• 合成移植物
• 自體移植

6. 牙科膜和移植骨替代物市場（按最終用戶）

• 醫院
• 門診手術中心
• 牙醫診所

第7章區域分析

• 北美洲
• 美國
• 加拿大
• 墨西哥
• 歐洲
• 英國
• 德國
• 法國
• 義大利
• 亞太地區
• 中國
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中東和非洲
• 南非
• 沙烏地阿拉伯
• 阿拉伯聯合大公國

第8章市場動態

• 市場促進因素
• 市場限制
• 市場機會
• COVID-19 市場影響

第9章 競爭態勢

• 主要企業
• 市場佔有率分析

第10章 公司簡介

• Geistlich Pharma AG
• Straumann Group（Switzerland）Ltd
• Medtronic
• Danaher Corporation
• Zimmer Biomet Holdings, Inc
• Illeris AG
• Botiss Biomaterials GmbH
• Osteogenics Biomedical Inc
• BioHorizons Corp
• CR Bard, Inc
• 11. Market Outlook and Opportunities
• Emerging Technologies
• Future Market Trends
• Investment Opportunities

第12章 附錄

• 簡稱列表
• 來源和參考文獻

Dental Membrane And Bone Graft Substitutes Market Size And Forecast

Dental Membrane And Bone Graft Substitutes Market size was valued at USD 2.07 Billion in 2024 and is projected to reach USD 3.97 Billion by 2032, growing at a CAGR of 8.46% from 2026 to 2032.

Dental membranes and bone graft substitutes are materials used in dental implant operations to promote bone regeneration and tissue repair. Dental membranes are utilized to cover and protect bone grafts, ensuring that they integrate well into the surrounding bone. Bone graft substitutes are materials that replace or supplement natural bone in locations where bone density is insufficient to support implant insertion. These alternatives may be synthetic, obtained from other animals, or processed from human tissue. They are essential in operations like guided bone regeneration and sinus augmentation, which help restore lost bone structure and promote new bone formation.

The dental membrane and bone graft replacements market is predicted to expand rapidly because of advances in materials science and increased demand for dental implants, which is being driven by the increasing prevalence of dental problems and cosmetic operations. biomaterial innovations, such as the creation of bioactive and resorbable membranes and grafts, are expected to improve the efficacy of these products.

The combination of regenerative medicine approaches, such as stem cell therapy and tissue engineering, could broaden their applicability. The aging population and growing awareness of oral health are expected to fuel market expansion, opening up prospects for new and improved dental regeneration solutions.

Global Dental Membrane And Bone Graft Substitutes Market Dynamics

The key market dynamics that are shaping the global dental membrane and bone graft substitutes market include:

Key Market Drivers:

Increasing Prevalence of Dental Diseases and Tooth Loss: The market is primarily driven by the rising frequency of dental diseases and tooth loss. According to the World Health Organization (WHO), almost 3.5 billion people worldwide suffer from oral disorders, with untreated dental caries (tooth decay) in permanent teeth being the most prevalent, impacting 2.3 billion people.

Rising Geriatric Population: The growing older population increases the need for dental membranes and bone graft substitutes due to the increased risk of dental problems and tooth loss. According to the United Nations Department of Economic and Social Affairs, by 2050, one in every six individuals worldwide will be beyond the age of 65 (16% of the population), up from one in every eleven in 2019 (9%).

Growing Dental Tourism: Dental tourism is growing in popularity, especially in poorer countries, leading to increased demand for modern dental procedures. According to Patients Beyond Borders, the dental tourism business is predicted to be valued at USD 5.83 Billion in 2021, with an annual growth rate of 12.1% between 2022 and 2030.

Key Challenges:

Regulatory Compliance: Ensuring regulatory compliance across several regions presents a substantial problem. Dental membranes and bone graft substitutes must adhere to strict requirements established by health authorities such as the FDA in the United States and the EMA in Europe. Navigating these requirements necessitates considerable testing and documentation, which may be expensive and time-consuming. Discrepancies in regulatory standards between nations can complicate international market entry and raise the risk of non-compliance, thereby delaying product introductions and limiting market access.

Patient Variability: Individual variances in patients' overall health, bone quality, and healing responses can all have an impact on the success of dental implant treatments. Variability in patient responses makes it difficult to produce universally effective dental membranes and bone graft alternatives. Tailoring items to meet various patient needs necessitates additional research and customization, which complicates product development and raises expenses.

Limited Clinical Evidence: The effectiveness of novel dental membranes and bone graft substitutes must be backed up by strong clinical evidence. Insufficient or inconclusive clinical data can impede product adoption and market acceptance. Ensure that goods have a demonstrated track record of safety and efficacy through extensive and well-documented clinical trials. The lack of strong clinical data can also cause distrust among dental professionals and undermine product credibility.

Key Trends:

Biodegradable Materials: There is a rising interest in developing biodegradable dental membranes and bone transplant alternatives. These materials are intended to spontaneously degrade and be absorbed by the body over time, eliminating the need for surgical removal and limiting potential consequences. Biodegradable solutions increase patient comfort while lowering the risk of long-term side effects. Advances in materials science are enabling the development of more effective and safe biodegradable solutions, which supports the industry's emphasis on improving patient outcomes and expediting dental procedures.

3D Printing Technology: 3D printing technology is transforming the dental membrane and bone graft substitute markets by allowing for the fabrication of highly customized and precise goods. This technology enables the creation of patient-specific implants and grafts with complicated features that precisely match the patient's anatomical requirements. It also enables rapid prototyping and development of novel materials. The capacity to personalize goods to individual needs improves the efficacy of dental treatments and broadens the possible uses of bone graft substitutes in regenerative dentistry.

Increasing Focus on Patient-Centric Care: There is a growing emphasis on patient-centered service in dentistry, which is driving the development of dental membranes and bone graft alternatives. This trend highlights the need to create products that not only improve therapeutic outcomes but also the total patient experience. Comfort, simplicity of use, and shortened recuperation time are increasingly important aspects of product development. By addressing these patient needs, businesses hope to develop more effective and patient-friendly solutions.

Global Dental Membrane And Bone Graft Substitutes Market Regional Analysis

Here is a more detailed regional analysis of the global dental membrane and bone graft substitutes market:

North America:

North America dominates the dental membrane and bone graft substitutes market, owing to its advanced healthcare infrastructure and increased awareness of oral health. The region's high prevalence of dental disorders, with over 26% of adults in the United States suffering from untreated tooth decay and around 46% exhibiting indicators of gum disease, highlights the need for improved dental therapies. The growing older population, which is expected to nearly double from 52 million in 2018 to 95 million by 2060, is especially vulnerable to oral problems, increasing demand for dental membranes and bone graft operations. The growing use of dental implants, with 3 million Americans already having implants and 500,000 new cases each year, strongly correlates with the need for these dental materials, which are required for successful implant surgeries.

Significant investments in dental R&D also drive market expansion. For instance, the National Institute of Dental and Craniofacial Research (NIDCR) obtained a budget of USD 501.23 Million for fiscal year 2022, a large increase over previous years. This investment is expected to drive advances in dental materials and methods, such as dental membranes and bone transplant alternatives. These factors-high prevalence of dental disorders, an aging population, increasing dental implant operations, and significant R&D investment-are projected to keep North America's dominant position in the global dental membrane and bone graft substitutes market.

Asia Pacific:

The Asia Pacific region is emerging as the fastest-growing market for dental membrane and bone graft alternatives, owing to increased urbanization, rising disposable incomes, and heightened awareness of oral health and aesthetic dentistry. The WHO has highlighted the high prevalence of dental illnesses, which has a huge impact on this region, with countries such as India having dental caries prevalence in adults of up to 82.4%. The prevalence of oral diseases is driving demand for improved dental treatments. Furthermore, the growing dental tourism business in Thailand, India, and Malaysia is driving up demand for high-quality dental operations, such as dental membranes and bone transplant alternatives.

The region's rising senior population, which is expected to more than double from 535 million in 2015 to 1.3 billion by 2050, is especially vulnerable to periodontal diseases and tooth loss, necessitating the use of innovative dental solutions. Increased government investments in dental health, such as India's National Oral Health Programme, are improving oral health infrastructure and raising awareness, further encouraging the use of modern treatments. These combined factors are likely to accelerate the Asia Pacific dental membrane and bone graft substitutes market, potentially making it the world's fastest-growing region.

Global Dental Membrane And Bone Graft Substitutes Market: Segmentation Analysis

The Global Dental Membrane And Bone Graft Substitutes Market is Segmented on the basis of Type of Membrane, Type of Bone Graft Substitute, End-User, And Geography.

Dental Membrane And Bone Graft Substitutes Market, By Type of Membrane

• Resorbable Membranes
• Non-resorbable Membranes

Based on Type of Membrane, the market is fragmented into Resorbable Membranes and Non-resorbable Membranes. Resorbable membranes now dominate the dental membrane and bone graft substitutes market due to their ability to eliminate the requirement for a second surgical treatment to remove the membrane. These membranes are often comprised of biocompatible materials that deteriorate slowly over time, making the treatment procedure easier for patients. Non-resorbable membranes are rapidly expanding because to their higher mechanical strength and capacity to maintain a stable barrier over an extended length of time, facilitating optimal bone regeneration. While they require a second surgery to remove, advances in material science and surgical procedures are reducing this disadvantage, adding to their growing popularity.

Dental Membrane And Bone Graft Substitutes Market, By Type of Bone Graft Substitute

• Allografts
• Xenografts
• Synthetic Grafts
• Autografts

Based on Type of Bone Graft Substitute, the market is segmented into Allografts, Xenografts, Synthetic Grafts, and Autografts. Autografts now lead the dental membrane and bone graft substitutes market because of their better osteoconductive and osteoinductive qualities, which promote optimal bone regeneration. However, the intrusive aspect of collecting bone from a patient's own body frequently causes donor site morbidity, limiting its broad use. Synthetic grafts are emerging as the most rapidly developing segment. These grafts provide various benefits, including uniform quality, a lower risk of disease transmission, and convenience of use. Ongoing breakthroughs in material science are resulting in the creation of synthetic grafts with higher biocompatibility and osteoconductive qualities, which is driving market expansion.

Dental Membrane And Bone Graft Substitutes Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Dental Clinics

Based on End-User, the market is segmented into Hospitals, Ambulatory Surgical Centers, and Dental Clinics. Dental clinics is dominating the dental membrane and bone graft substitutes market owing to their extensive availability, emphasis on oral healthcare, and established patient relationships. Ambulatory surgery clinics are rapidly expanding because they provide specialized equipment and experience for difficult dental treatments including bone grafting and membrane insertion. The growing need for minimally invasive and efficient treatments is driving patients to ambulatory surgery facilities, which is contributing to their market growth.

Dental Membrane And Bone Graft Substitutes Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World
• On the basis of Geography, the Global Dental Membrane And Bone Graft Substitutes Market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America dominates the dental membrane and bone graft substitutes market, owing to its advanced healthcare infrastructure, large geriatric population, and high acceptance rates of advanced dental procedures. Asia Pacific, on the other hand, is the fastest-growing region, owing to rapid urbanization, increased disposable income, expanding dental tourism, and heightened awareness of oral health.

Key Players

The "Global Dental Membrane And Bone Graft Substitutes Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are Geistlich Pharma AG, Straumann Group (Switzerland) Ltd, Medtronic, Danaher Corporation, Zimmer Biomet Holdings, Inc., Illeris AG, Botiss Biomaterials GmbH, Osteogenics Biomedical, Inc., BioHorizons Corp, and C.R. Bard, Inc.

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Dental Membrane And Bone Graft Substitutes Market Recent Developments
• In October 2023, ZimVie, Inc., a worldwide life sciences business, introduced the Biotivity A/C Plus Membrane in the United States. This barrier membrane contains growth factors that help in jaw restoration and implant stability. This move increases ZimVie's position in dental biomaterials, with an emphasis on wound healing enhancement.
• In May 2022, BONESUPPORT AB, an orthobiologics business, stated that Cerament G had been granted market authorization by the United States Food and Drug Administration. It is the first and only bone graft substitute intended to fill gaps during surgical operations and treat bone abnormalities.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Dental Membrane And Bone Graft Substitutes Market, By Type of Membrane

• Resorbable Membranes
• Non-resorbable Membranes

5.Dental Membrane And Bone Graft Substitutes Market, By Type of Bone Graft Substitute

• Allografts
• Xenografts
• Synthetic Grafts
• Autografts

6.Dental Membrane And Bone Graft Substitutes Market, By End-User

• Hospitals
• Ambulatory Surgical Centers
• Dental Clinics

7. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

8. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

9. Competitive Landscape

• Key Players
• Market Share Analysis

10. Company Profiles

• Geistlich Pharma AG
• Straumann Group (Switzerland) Ltd
• Medtronic
• Danaher Corporation
• Zimmer Biomet Holdings, Inc
• Illeris AG
• Botiss Biomaterials GmbH
• Osteogenics Biomedical Inc
• BioHorizons Corp
• C.R. Bard, Inc
• 11. Market Outlook and Opportunities
• Emerging Technologies
• Future Market Trends
• Investment Opportunities

12. Appendix

• List of Abbreviations
• Sources and References